MedTrace Logo

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

NCT03699995 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2026-04-08

No results posted yet for this study

Summary

This trial studies how well MoleMapper, Visiomed, and confocal microscopy work in screening participants for melanoma. Analyzing images (photographs) made with three different portable imaging systems may be as good as a visit to a dermatologist's office for finding melanomas before they can spread.

Conditions

Interventions

OTHER

Confocal Microscopy

Undergo confocal microscopy

OTHER

Dermoscopy

Undergo digital dermoscopy

PROCEDURE

Imaging Procedure

Undergo MoleMapper/Sklip app/native smartphone camera app imaging with smartphone

DRUG

Lidocaine

Given SC

PROCEDURE

Punch Biopsy

Undergo punch biopsy

PROCEDURE

Shave Biopsy

Undergo shave biopsy

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Joanna Ludzik, MD · OHSU Knight Cancer Institute

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-18
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699995 on ClinicalTrials.gov